Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells
April L. Blajeski, … , Timothy J. Kottke, Scott H. Kaufmann
April L. Blajeski, … , Timothy J. Kottke, Scott H. Kaufmann
Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):91-99. https://doi.org/10.1172/JCI13275.
View: Text | PDF
Article Development

G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells

  • Text
  • PDF
Abstract

Research Article

Authors

April L. Blajeski, Vy A. Phan, Timothy J. Kottke, Scott H. Kaufmann

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Two types of behavior following treatment of human breast cancer cell li...
Two types of behavior following treatment of human breast cancer cell lines with microtubule-depolymerizing agents. (a) After a 24-hour treatment with 1 μM nocodazole, adherent and nonadherent MDA-MB-468 or MCF-7 cells were combined, stained with Hoechst 33258, and examined by fluorescence microscopy. Note that MDA-MB-468 cells remained in interphase, whereas many MCF-7 cells arrested in mitosis. (b–d) Breast cancer cells (filled triangles, MCF-7; filled circles, HS0578T; open triangles, BT20; open circles, MDA-MB-468) were treated with 1 μM nocodazole (b), 100 nM vincristine (c), or 100 nM paclitaxel (d) for various periods of time. Alternatively, HMECs (e) were treated with these agents for 14 hours, a length of time chosen because this isolate doubled every 16 hours. After adherent and nonadherent cells were combined, the morphology of 300 or more nuclei in each sample was scored by fluorescence microscopy. In b–d, representative individual experiments are shown and the degree of variation is indicated in the text. In e, the mean and range of two experiments are shown. Ctrl, control; Pacl, paclitaxel; Noco, nocodazole; Vin, vincristine.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts